Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy

Annals of Medicine

Volumn 32, Issue 2, 2000, Pages 94-106

  Reyes, Humberto ^a,c   Sjövall, Jan ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

Bile acid; Cholestasis of pregnancy; Chromatography; Mass spectrometry; N acetylglucosaminide; Progesterone metabolite; Steroid; Sulfate; Ursodeoxycholic acid

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; ESTROGEN; PROGESTERONE; URSODEOXYCHOLIC ACID;

BILE ACID METABOLISM; BILE ACID SYNTHESIS; ENVIRONMENTAL FACTOR; ESTROGEN BLOOD LEVEL; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GLUCURONIDATION; HORMONE METABOLISM; HORMONE URINE LEVEL; HUMAN; HYDROXYLATION; INTRAHEPATIC CHOLESTASIS; LIVER TOXICITY; METABOLITE; PATHOGENESIS; PLACENTAL TRANSFER; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROGESTERONE URINE LEVEL; PRURITUS; REVIEW; SULFATION;

EID: 1642586761     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853890009011758     Document Type: Review

References (96)

1. Svanborg A. A study of recurrent jaundice of pregnancy. Acta Obstet Gynecol Scand 1954; 33: 434-44.
2. Reyes H, Radrigán ME, Schramm G, Katz R. Incidence of idiopathic jaundice and pruritus of pregnancy in Chilean population (in Spanish). Rev Med Chil 1968; 96: 409-14.
3. Reyes H. The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile. Hepatology 1982; 2: 87-96.
4. Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Gastroenterol Clin North Am 1992; 21: 905-21.
5. Reyes H. Intrahepatic cholestasis. A puzzling disorder of pregnancy. J Gastroenterol Hepatol 1997; 12: 211-6.
6. Bacq Y. Intrahepatic cholestasis of pregnancy. Clin Liver Dis 1999; 3: 1-13.
7. McDonald JA. Cholestasis of pregnancy. J Gastroenterol Hepatol 1999; 14: 515-8.
8. Reyes H, González MC, Ribalta J, Latorre R, Segovia N, Montt J, et al. Cholestasis of pregnancy: clinical and biochemical variability (in Spanish). Rev Med Chil 1982; 110: 631-9.
9. Reyes H, Radrigán ME, González MC, Latorre R, Ribalta J, Segovia N, et al. Steatorrhea in patients with intrahepatic cholestasis of pregnancy. Gastroenterology 1987; 93: 584-90.
10. Reyes H, Ribalta J, González MC, Segovia N, Oberhauser E. Sulfobromophthalein clearance tests before and after ethinyl oestradiol administration, in women and men with familial history of intrahepatic cholestasis of pregnancy. Gastroenterology 1981; 81: 226-31.
11. Engström J, Hellström K, Posse N, Sjövall J. Recurrent cholestasis of pregnancy. Treatment with cholestyramine of one case with an unusually early onset. Acta Obstet Gynecol Scand 1970; 49: 29-34.
12. Olsson R, Tysk C, Aldenborg F, Holm B. Prolonged postpartum course of intrahepatic cholestasis of pregnancy. Gastroenterology 1993; 105: 267-71.
13. Leevy CB, Koneru B, Klein KM. Recurrent familial prolonged intrahepatic cholestasis of pregnancy associated with chronic liver disease. Gastroenterology 1997; 113: 966-72.
14. Reyes H, Palma J, Ribalta J. Recurrent familial cholestasis disclosed by pregnancy. Gastroenterology 1998; 114: 1354-5.
15. Acuña R, González MC. Hypoprothrombinemia and bleeding associated to treatment with cholestyramine (in Spanish). Rev Med Chil 1977; 105: 27-8.
16. Sadler LC, Lane M, North R. Severe foetal intracranial haemorrhage during treatment with cholestyramine for intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol 1995; 102: 169-73.
17. Laatikainen T, Ikonen E. Fetal prognosis in obstetric hepatosis. Ann Chir Gynaecol Fenn 1975; 64: 155-64.
18. Shaw D, Frohlich J, Wittman BA, Willms M. A prospective study of 18 patients with cholestasis of pregnancy. Am J Obstet Gynecol 1982; 142: 621-5.
19. Laatikainen T, Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynecol Obstet 1984; 22: 91-4.
20. Fisk NM, Storey GNB. Foetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 1988; 95: 1137-43.
21. Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT, et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994; 170: 890-5.
22. Davies MH, da Silva RC, Jones SR, Weaver JB, Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid Gut 1995; 37: 580-4.
23. Heinonen S, Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol 1999; 94: 189-93.
24. Berg B, Helm G, Petersohn L, Tryding N. Cholestasis of pregnancy. Clinical and laboratory studies. Acta Obstet Gynecol Scand 1986; 65: 107-13.
25. Reyes H, Simon FR. Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin Liver Dis 1993; 13: 289-301.
26. Adlercreutz H, Tenhunen R. Some aspects of the interaction between natural and synthetic female sex hormones and the liver. Am J Med 1970; 49: 630-48.
27. Adlercreutz H, Tikkanen MJ, Wichmann K, Svanborg A, Ånberg Å. Recurrent jaundice in pregnancy. IV. Quantitative determination of urinary and biliary estrogens, including studies in pruritus gravidarum. J Clin Endocrinol Metab 1974; 38: 51-7.
28. Sjövall K. Gas Chromatographic determination of steroid sulphates in plasma during pregnancy. Ann Clin Res 1970; 2: 393-408.
29. Sjövall K. Sulphates of pregnanolones, pregnanediols and 16-hydroxysteroids in plasma from pregnant women. Ann Clin Res 1970; 2: 409-13.
30. Sjövall J, Sjövall K. Steroid sulphates in plasma from pregnant women with pruritus and elevated bile acid levels. Ann Clin Res 1970; 2: 321-38.
31. Eriksson H, Gustafsson J-Å, Sjövall J, Sjövall K. Excretion of neutral steroids in urine and faeces of women with intrahepatic cholestasis of pregnancy. Steroids Lipids Res 1973; 3: 30-48.
32. Laatikainen T, Karjalainen O, Jänne O. Excretion of progesterone metabolites in urine and bile of pregnant women with intrahepatic cholestasis. J Steroid Biochem 1973; 4: 641-8.
33. Laatikainen TJ, Peltonen JI, Nylander PL. Effect of maternal intrahepatic cholestasis on fetal steroid metabolism. J Clin Invest 1974; 53: 1709-15.
34. Giusti G, Piccinino F, Ricciardi I, Delrio G, Sagnelli E, Manzillo G. Abnormal steroid sulphate in plasma of women with intrahepatic cholestasis of pregnancy. Acta Hepatogastroenterol 1979; 26: 203-6.
35. Laatikainen T, Karjalainen O. Excretion of conjugates of neutral steroids in human bile during late pregnancy. Acta Endocrinol (Copenh) 1982; 69: 775-88.
36. Vore M. Estrogen cholestasis. Membranes, metabolites, or receptors? Gastroenterology 1987; 93: 643-9.
37. Adlercreutz H, Martin F. Biliary excretion and intestinal metabolism of progesterone and estrogens in man. J Steroid Biochem 1980; 13: 231-44.
38. Palma J, Reyes H, Ribalta J, Iglesias J, González MC, Hernández I, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. In: Paumgartner G, Stiehl A, Gerok W, eds. Bile acids as therapeutic agents: from basic science to clinical practice. Dordrecht, the Netherlands: Kluwer Academic Publishers; 1991: 319-22.
39. Palma J, Reyes H, Ribalta J, Iglesias J, González M, Hernández I, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy (preliminary report) (in Spanish). Rev Med Chil 1991; 119: 169-71.
40. Marpeau L, Chazouillière D, Rhimi Z, Poupon R, Pigne A, Barrat J. Pregnancy-associated idiopathic intrahepatic cholestasis. Hypothesis of physiopathology: a therapeutic case report. Fetal Diagn Ther 1991; 6: 120-5.
41. Mazella G, Rizzo N, Salzetta A, Iampieri R, Bovicelli L, Roda E. Management of intrahepatic cholestasis in pregnancy. Lancet 1991; 338: 1594-5.
42. Palma J, Reyes H, Ribalta J, Iglesias J, González MC, Hernández I, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992; 15: 1043-7.
43. Brites D, Poeiras J, Rodrigues C. Intrahepatic cholestasis of pregnancy: etiopathogenesis, prognosis and treatment. Acta Med Port 1994; 7: 181-8.
44. Floreani A, Paternoster D, Grella V, Sacco S, Gangemi M, Chiaramonte M. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol 1994; 101: 64-5.
45. Palma J, Reyes H, Ribalta J, Hernández I, Sandoval L, Almuna R, et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol 1997; 27: 1022-8.
46. Hofmann AF. Bile acid hepatotoxicity and the rationale of UDCA therapy in chronic cholestatic liver disease: some hypotheses. In: Paumgartner G, Stiehl A, Barbara L, Roda E, eds. Strategies for the treatment of hepatobiliary diseases. Dordrecht, the Netherlands: Kluwer Academic Publishers; 1990: 13-34.
47. Beuers U, Spengler U, Zwiebel FM, Pauletzki J, Fisher S, Paumgartner G. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology 1992; 15: 603-8.
48. ++ mechanisms defective in cholestasis. J Clin Invest 1993; 92: 2984-93.
49. Boyer JL, Soroka CJ. Vesicle targeting to the apical domain regulates bile excretory function in isolated rat hepatocyte couplets. Gastroenterology 1995; 109: 1600-11.
50. Beuers U, Throckmorton DC, Anderson MS, Isales CM, Thasler W, Kullak-Ublick GA, et al. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology 1996; 110: 1553-63.
51. Dubner H, Fromm H. Ursodeoxycholic acid treatment of intrahepatic cholestasis of pregnancy: observations on efficacy and safety. Gastroenterology 1993; 104: 660-1.
52. Laatikainen T, Ikonen E. Serum bile acids in cholestasis of pregnancy. Obstet Gynecol 1977; 50: 313-8.
53. Heikkinen J, Mäentausta O, Ylöstalo P, Jänne O. Changes in serum bile concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br J Obstet Gynaecol 1981; 88: 240-5.
54. Heikkinen J. Serum bile acids in the early diagnosis of intrahepatic cholestasis of pregnancy. Obstet Gynecol 1983; 61: 581-7.
55. Bacq Y, Sapey T, Bréchet M-C, Pierre F, Fignon A, Dubois F. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 1997; 26: 358-64.
56. Almé B, Bremmelgaard A, Sjövall J, Thomassen P. Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerised gas-liquid chromatography-mass spectrometry. J Lipid Res 1977; 18: 339-62.
57. Thomassen P. Urinary bile acids in late pregnancy and in recurrent intrahepatic cholestasis of pregnancy. Eur J Clin Invest 1979; 9: 425-32.
58. Meng L-J, Sjövall J. Method for combined analysis of profiles of conjugated progesterone metabolites and bile acids in serum and urine of pregnant women. J Chromatogr Biomed Sci Appl 1997; 688: 11-26.
59. Axelson M, Aly A, Sjövall J. Levels of 7α-hydroxy-4-cholesten-3-one in plasma reflect rates of bile acid synthesis in man. FEBS Lett 1988; 239: 324-8.
60. Axelson M, Björkhem I, Reihner E, Einarsson K. The plasma level of 7α-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7α-hydroxylase in man. FEBS Lett 1991; 284: 216-8.
61. Sauter G, Berr F, Beuers U, Fischer S, Paumgartner G. Serum concentrations of 7α-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans. Hepatology 1996; 24: 123-6.
62. Meng L-J, Reyes H, Palma J, Hernández I, Ribalta J, Sjövall J. Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy. J Hepatol 1997; 27: 346-57.
63. Meng L-J, Reyes H, Axelson M, Palma J, Hernández I, Ribalta J, et al. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect or ursodeoxycholic acid therapy. Hepatology 1997; 26: 1573-9.
64. Meng L-J, Reyes H, Palma J, Hernández I, Ribalta J, Sjövall J. Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. J Hepatol 1997; 27: 1029-40.
65. Sjövall K, Sjövall J. Serum bile acid levels in pregnancy with pruritus. Clin Chim Acta 1966; 13: 207-11.
66. Laatikainen T, Lehtonen P, Hesso A. Biliary bile acids in uncomplicated pregnancy and in cholestasis of pregnancy. Clin Chim Acta 1978; 85: 145-50.
67. Bacq Y, Myara A, Brechot M-C, Hamon C, Studer E, Trivin F, et al. Serum conjugated bile acid profile during intrahepatic cholestasis of pregnancy. J Hepatol 1995; 22: 66-70.
68. Laatikainen T, Hesso A. Determination of serum bile acids by capillary gas-liquid chromatography. Clin Chim Acta 1975; 64: 63-8.
69. Laatikainen T. Postprandial serum bile acids in cholestasis of pregnancy. Ann Clin Res 1978; 10: 307-12.
70. Heikkinen J, Ylöstalo P, Mäentausta O, Jänne O. Bile acids in maternal serum, umbilical cord serum and amniotic fluid of healthy women, women with pruritus and patients with intrahepatic cholestasis of pregnancy. J Obstet Gynaecol 1983; 4: 17-20.
71. Heikkinen J, Mäentausta O, Ylöstalo P, Jänne O. Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine. Eur J Obstet Gynecol Reprod Biol 1982; 14: 153-62.
72. Brites D, Rodrigues CMP, Oliveira N, Cardoso MC, Graça LM. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy. J Hepatol 1998; 28: 91-8.
73. St Pyrek J, Lester R, Adcock EW, Stanghvi AT. Constituents of human meconium - 1. Identification of 3-hydroxy-etianic acids. J Steroid Biochem 1983; 18: 341-51.
74. 4 bile acids in liver disease. Lancet 1988; i: 1283-4.
75. 4-3-oxosteroid 5 β-reductase deficiency described in identical twins with neonatal hepatitis. J Clin Invest 1988; 82: 2148-57.
76. Stieger B, Zhang J, O'Neill B, Sjövall J, Meier PJ. Differential interaction of bile acids from patients with inborn errors of bile acid synthesis with hepatocellular bile acid transporters. Eur J Biochem 1997; 244: 39-44.
77. Deleze G, Paumgartner G, Karlaganis G, Giger W, Reinhard M, Sidiropoulos D. Bile acid pattern in human amniotic fluid. Eur J Clin Invest 1978; 8: 41-5.
78. Laatikainen TJ, Lehtonen PJ, Hesso AE. Fetal sulfated and nonsulfated bile acids in intrahepatic cholestasis of pregnancy. J Lab Clin Med 1978; 92: 185-93.
79. Heikkinen J, Mäentausta O, Tuimala R, Ylöstalo P, Jänne O. Amniotic fluid bile acids in normal and pathologic pregnancy. Obstet Gynecol 1980; 50: 60-4.
80. Serrano MA, Brites D, Larena MG, Monte MJ, Bravo MP, Oliveira N, et al. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta. J Hepatol 1998; 28: 829-39.
81. Laatikainen T. Fetomaternal relationships of serum bile acids in uncomplicated pregnancy. Scand J Clin Lab Invest 1977; 37: 605-8.
82. Rodrigues CMP, Marin JJG, Brites D. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment. Gut 1999; 45: 446-52.
83. Meng L-J, Reyes H, Palma J, Hernández I, Ribalta J, Sjövall J. Progesterone metabolism in normal human pregnancy and in patients with intrahepatic cholestasis of pregnancy. In: Reyes HB, Leuschner U, Arias IM, eds. Pregnancy, sex hormones and the liver. Dordrecht, the Netherlands: Kluwer Academic Publishers; 1996: 91-100.
84. Baillie TA, Curstedt T, Sjövall K, Sjövall J. Production rates and metabolism of sulphates of 3 β-hydroxy-5 α-pregnane derivatives in pregnant women. J Steroid Biochem 1980; 13: 1473-86.
85. Anderson RA, Baillie TA, Axelson M, Cronholm T, Sjövall K, Sjövall J. Stable isotope studies on steroid metabolism and kinetics: sulfates of 3 β-hydroxy-5 α-pregnane derivatives in human pregnancy. Steroids 1990; 55: 443-57.
86. Huang L, Hoffman T, Vore M. Adenosine triphosphate-dependent transport of estradiol-17 β-(β-D-glucuronide) in membrane vesicles by MDR1 expressed in insect cells. Hepatology 1998; 28: 1371-7.
87. de Vree JML, Jacquemin E, Sturm E, Cresteil D, Bosma PJ, Aten J, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A 1998; 95: 282-7.
88. Strautnieks SS, Bull LN, Knisely AS, Kocoshis S, Dahl N, Arnell H, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998; 20: 233-8.
89. Tygstrup N, Steig BA, Juin JA, Bull LN, Houwen RHJ. Recurrent familial intrahepatic cholestasis in the Faeroe Islands. Phenotypic heterogeneity but genetic homogeneity. Hepatology 1999; 29: 506-8.
90. Trauner M, Meier PJ, Boyer JL. Molecular regulation of hepatocellular transport systems in cholestasis. J Hepatol 1999; 31: 165-78.
91. Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999; 353: 210-11.
92. Davies MH, Ngong JM, Yucesoy M, Acharya SK, Mills CO, Weaver JB, et al. The adverse influence of pregnancy upon sulphation: a clue to the pathogenesis of intrahepatic cholestasis of pregnancy. J Hepatol 1994; 21: 1127-34.
93. Ribalta J, Reyes H, Hernández I, Fuentes O, Báez M, González M, et al. Can a deficiency of selenium influence the pathogenesis of cholestasis of pregnancy? (in Spanish) Gastroenterol Hepatol 1995; 18: 114-20.
94. Reyes H, Báez ME, González MC, Hernández I, Palma J, Ribalta J, et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals in Chile. J Hepatol (in press).
95. Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, Meier PJ. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile acid export pump (Bsep) of rat liver. Gastroenterology 2000; 118: 422-30.
96. Hirohashi T, Suzuki H, Takikawa H, Sugiyama Y. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J Biol Chem 2000; 275: 2905-10.